Blair William & CO Bei Gene, Ltd. Transaction History

Blair William & CO

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$215.53 - $274.5 $862 - $1,098	4 Added 0.4%	1,004 $216,000
Q4 2022 Feb 10, 2023	BUY	$125.51 - $229.3 $125,510 - $229,300	1,000 New	1,000 $219,000
Q2 2022 Aug 10, 2022	SELL	$121.11 - $216.05 $131,283 - $234,198	-1,084 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$146.52 - $269.56 $146 - $269	1 Added 0.09%	1,084 $204,000
Q4 2021 Feb 14, 2022	BUY	$248.56 - $389.34 $82,770 - $129,650	333 Added 44.4%	1,083 $293,000
Q3 2021 Nov 12, 2021	SELL	$249.6 - $403.14 $12,480 - $20,157	-50 Reduced 6.25%	750 $272,000
Q1 2021 May 13, 2021	SELL	$260.64 - $382.12 $16,159 - $23,691	-62 Reduced 7.19%	800 $278,000
Q4 2020 Feb 09, 2021	SELL	$221.31 - $316.61 $9,516 - $13,614	-43 Reduced 4.75%	862 $223,000
Q3 2020 Nov 06, 2020	BUY	$189.18 - $286.44 $171,207 - $259,228	905 New	905 $259,000
Q1 2019 May 14, 2019	SELL	$122.82 - $151.83 $183,001 - $226,226	-1,490 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$152.5 - $216.77 $6,100 - $8,670	40 Added 2.76%	1,490 $229,000
Q1 2018 May 15, 2018	SELL	$97.41 - $177.22 $79,389 - $144,434	-815 Reduced 35.98%	1,450 $244,000
Q4 2017 Feb 14, 2018	SELL	$79.6 - $114.73 $7,959 - $11,473	-100 Reduced 4.23%	2,265 $221,000
Q3 2017 Nov 13, 2017	BUY	$66.19 - $103.46 $156,539 - $244,682	2,365	2,365 $245,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.